What is the appropriate method for performing a skin biopsy to diagnose amyloidosis and what subsequent work‑up should be undertaken?

Skin Biopsy for Amyloidosis Diagnosis

For diagnosing systemic amyloidosis, perform an incision (spindle-shaped) biopsy of the abdominal wall that includes subcutaneous fat to a depth of at least 10 mm, combined with Congo red staining and mass spectrometry-based protein typing. 1

Biopsy Technique

Preferred Method: Incision Biopsy

• Take a spindle-shaped incision biopsy with a long axis ≥10 mm from the abdominal wall
• Ensure adequate depth to capture subcutaneous fat (ideally >10 mm deep, as amyloid deposits can occur up to 12 mm deep) 2
• This technique provides 100% sensitivity when depth exceeds 10 mm, compared to only 24% for shallower biopsies 3

Alternative: Punch Biopsy

• Multiple-site punch biopsies (1-5 sites) show 46.4% sensitivity 2
• Less reliable than incision biopsy but acceptable if incision technique unavailable
• Must include adequate subcutaneous fat tissue

Diagnostic Approach Algorithm

Step 1: Choose Biopsy Strategy

Two acceptable approaches exist for AL amyloidosis 1:

Option A (Less Invasive First):

1. Abdominal fat pad aspiration/biopsy + bone marrow biopsy
2. If negative for Congo red staining → proceed to affected organ biopsy

Option B (Direct):

1. Biopsy the affected organ directly (heart, kidney, liver)

Critical caveat: Abdominal fat pad biopsy sensitivity varies by amyloidosis type:

• AL amyloidosis: 64-84% sensitive 1, 3
• ATTRv: 45% sensitive 1
• ATTRwt: Only 15% sensitive 1

Step 2: Histological Confirmation

• Congo red staining is mandatory - look for apple-green birefringence under polarized microscopy 4
• Light microscopy shows amorphous pink deposits in interstitium 4
• Fatty tissue is the most common site of amyloid deposition 2

Step 3: Protein Typing (Essential)

Mass spectrometry (LC-MS/MS) is the gold standard with 88% sensitivity and 96% specificity 1

• Superior to immunohistochemistry alone
• Critical because >10% of patients with monoclonal gammopathy can have ATTR deposits 1
• Send Congo red-positive specimens to reference laboratory if LC-MS/MS unavailable locally

Alternative methods (less reliable):

• Immunohistochemistry with antibodies against amyloid A, κ- and λ-light chains, and TTR 4
• Immunogold immunoelectron microscopy 1

Subsequent Work-Up

For AL Amyloidosis

Once tissue shows amyloid deposits, you must demonstrate plasma cell dyscrasia 1:

1. Monoclonal protein screen:

   • Serum free light chains (sFLC)
   • Serum immunofixation electrophoresis (SIFE)
   • Urine immunofixation electrophoresis (UIFE)
   • Do NOT use SPEP/UPEP alone - insufficient sensitivity 1

2. Bone marrow biopsy showing clonal plasma cells (sensitivity 69% for finding amyloid deposits) 1

3. Exclude multiple myeloma or B-cell lymphoproliferative disorders 1

For ATTR Amyloidosis

If TTR amyloid detected 4:

• DNA mutational analysis mandatory to differentiate hereditary (ATTRv) from wild-type (ATTRwt)

Organ Involvement Assessment

After establishing amyloidosis diagnosis, evaluate extent of organ involvement 4:

Cardiac evaluation:

• Echocardiography with longitudinal strain (look for apical sparing pattern) 5
• BNP/NT-proBNP (93% sensitivity, 90% specificity for cardiac involvement) 4
• Troponin levels
• Consider cardiac MRI with late gadolinium enhancement 4, 5
• Technetium-99m pyrophosphate scan (distinguishes AL from ATTR) 4

Renal evaluation:

• 24-hour urine protein collection
• Urine immunofixation 6

Hepatic evaluation:

• Alkaline phosphatase
• Abdominal CT or ultrasound if elevated 6

Critical Pitfalls to Avoid

1. Inadequate biopsy depth - Most common cause of false negatives; must reach subcutaneous fat >10 mm deep 2, 3

2. Relying on Congo red alone without protein typing - Cannot distinguish AL from ATTR without mass spectrometry or immunohistochemistry 1

3. Using SPEP/UPEP to exclude AL amyloidosis - Insufficient sensitivity; must use immunofixation and free light chains 1

4. Assuming negative fat pad biopsy excludes amyloidosis - Sensitivity only 43-89% overall; if clinical suspicion high, proceed to affected organ biopsy 4, 3, 7

5. Missing concomitant MGUS in ATTR patients - 10-40% of ATTR patients have monoclonal protein; requires hematology consultation to differentiate 1

Combining Biopsy Sites

For maximum sensitivity in AL amyloidosis, combine abdominal fat pad with rectal mucosal biopsy - achieves 98.9% sensitivity with Congo red staining 7. However, this is primarily relevant when AL amyloidosis is strongly suspected and initial fat pad biopsy is negative.